View ValuationIBU-tec advanced materials 향후 성장Future 기준 점검 5/6IBU-tec advanced materials (는) 각각 연간 74.5% 및 26.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 74.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 4.7% 로 예상됩니다.핵심 정보74.5%이익 성장률74.80%EPS 성장률Chemicals 이익 성장38.9%매출 성장률26.5%향후 자기자본이익률4.70%애널리스트 커버리지Low마지막 업데이트14 Apr 2026최근 향후 성장 업데이트공시 • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.모든 업데이트 보기Recent updatesUpcoming Dividend • May 13Upcoming dividend of €0.12 per shareEligible shareholders must have bought the stock before 20 May 2026. Payment date: 22 May 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (4.0%).공시 • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €47.0m (down 10.0% from FY 2024). Net income: €5.7k (up €5.31m from FY 2024). Profit margin: 0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.공시 • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026New Risk • Mar 20New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €209k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (€209k net loss in 2 years). Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (€84.8m market cap, or US$98.2m).New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change).New Risk • Feb 11New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €82.4m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Market cap is less than US$100m (€82.4m market cap, or US$97.9m).New Risk • Jan 01New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €1.3m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (27% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (€1.3m net loss in 2 years).공시 • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €54.1m (up 10% from FY 2023). Net loss: €5.31m (loss widened 113% from FY 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom.공시 • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.공시 • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€28.3m market cap, or US$30.8m).공시 • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom.공시 • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024공시 • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 35%After last week's 35% share price gain to €12.68, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 20x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 61% over the past year.공시 • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €9.99, the stock trades at a trailing P/E ratio of 41.5x. Average trailing P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 71% over the past year.Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €13.12, the stock trades at a trailing P/E ratio of 54.9x. Average trailing P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 60% over the past year.Valuation Update With 7 Day Price Move • Jan 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €13.22, the stock trades at a trailing P/E ratio of 48.1x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 63% over the past year.New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).Valuation Update With 7 Day Price Move • Oct 23Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €18.54, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 15x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 9.8% over the past year.New Risk • Oct 21New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €92.1m (US$97.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€92.1m market cap, or US$97.5m).Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom.New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio).이익 및 매출 성장 예측LSE:0UNS - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028722312112/31/2027571328112/31/202637-2-313112/31/2025460514N/A9/30/202546-1411N/A6/30/202546-338N/A3/31/202549-439N/A12/31/202452-529N/A9/30/202451-618N/A6/30/202449-606N/A3/31/202449-4-34N/A12/31/202349-2-52N/A9/30/202350-1-91N/A6/30/2023501-130N/A3/31/2023521-13-2N/A12/31/2022541-13-3N/A9/30/2022541N/AN/AN/A6/30/2022541-10-5N/A3/31/2022491-8-3N/A12/31/2021450-6-1N/A9/30/202142-1N/AN/AN/A6/30/202139-2-6-3N/A3/31/2021360-31N/A12/31/202033114N/A9/30/2020341N/AN/AN/A6/30/2020352510N/A3/31/202042127N/A12/31/2019491-24N/A9/30/2019572N/AN/AN/A6/30/2019512N/A2N/A3/31/2019422N/A3N/A12/31/2018332N/A3N/A9/30/2018180N/A3N/A6/30/201817-1N/A2N/A3/31/2018170N/A2N/A12/31/2017170N/A1N/A9/30/2017182N/A1N/A6/30/2017183N/A2N/A3/31/2017183N/A3N/A12/31/2016183N/A4N/A12/31/2015173N/A4N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 0UNS 의 연간 예상 수익 증가율(74.5%)이 saving rate(3.4%)보다 높습니다.수익 vs 시장: 0UNS 의 연간 수익(74.5%)이 UK 시장(11.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 0UNS 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 0UNS 의 수익(연간 26.5%)이 UK 시장(연간 4.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 0UNS 의 수익(연간 26.5%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 0UNS의 자본 수익률은 3년 후 4.7%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 04:19종가2026/05/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스IBU-tec advanced materials AG는 2명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Patrick SpeckMontega AGOliver SchwarzWarburg Research GmbH
공시 • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.
Upcoming Dividend • May 13Upcoming dividend of €0.12 per shareEligible shareholders must have bought the stock before 20 May 2026. Payment date: 22 May 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (4.0%).
공시 • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.
Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €47.0m (down 10.0% from FY 2024). Net income: €5.7k (up €5.31m from FY 2024). Profit margin: 0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.
공시 • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026
New Risk • Mar 20New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €209k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (€209k net loss in 2 years). Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (€84.8m market cap, or US$98.2m).
New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change).
New Risk • Feb 11New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €82.4m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Market cap is less than US$100m (€82.4m market cap, or US$97.9m).
New Risk • Jan 01New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €1.3m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (27% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (€1.3m net loss in 2 years).
공시 • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025
Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €54.1m (up 10% from FY 2023). Net loss: €5.31m (loss widened 113% from FY 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom.
공시 • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.
공시 • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.
New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€28.3m market cap, or US$30.8m).
공시 • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025
Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom.
공시 • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024
공시 • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 35%After last week's 35% share price gain to €12.68, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 20x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 61% over the past year.
공시 • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024
New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €9.99, the stock trades at a trailing P/E ratio of 41.5x. Average trailing P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 71% over the past year.
Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €13.12, the stock trades at a trailing P/E ratio of 54.9x. Average trailing P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 60% over the past year.
Valuation Update With 7 Day Price Move • Jan 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €13.22, the stock trades at a trailing P/E ratio of 48.1x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 63% over the past year.
New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).
Valuation Update With 7 Day Price Move • Oct 23Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €18.54, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 15x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 9.8% over the past year.
New Risk • Oct 21New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €92.1m (US$97.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€92.1m market cap, or US$97.5m).
Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom.
New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio).